CytRx Corporation Company Profile (NASDAQ:CYTR)

About CytRx Corporation

CytRx Corporation logoCytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue sarcoma (STS) whose tumors have progressed after treatment with chemotherapy. It is also involved in evaluating aldoxorubicin in a Phase IIb clinical trial in small cell lung cancer; a Phase II clinical trial in human immunodeficiency virus-related Kaposi's sarcoma; a Phase II clinical trial in patients with late-stage glioblastoma (brain cancer); a Phase Ib trial in combination with ifosfamide in patients with STS, and a Phase Ib trial in combination with gemcitabine in subjects with metastatic solid tumors. It is engaged in the pre-clinical development for DK049, an anti-cancer drug conjugate that utilizes its Linker Activated Drug Release (LADR) technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CYTR
  • CUSIP:
Key Metrics:
  • Previous Close: $0.46
  • 50 Day Moving Average: $0.4218
  • 200 Day Moving Average: $0.4985
  • 52-Week Range: $0.36 - $3.66
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.92
  • P/E Growth: 0.0000
  • Market Cap: $44.58M
  • Outstanding Shares: 96,943,000
  • Beta: 1.34
Profitability:
  • Return on Equity: -213.82%
  • Return on Assets: -99.93%
Debt:
  • Debt-to-Equity Ratio: 0.86%
  • Current Ratio: 3.06%
  • Quick Ratio: 3.06%
Additional Links:
Companies Related to CytRx Corporation:

Analyst Ratings

Consensus Ratings for CytRx Corporation (NASDAQ:CYTR) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $4.10 (791.50% upside)

Analysts' Ratings History for CytRx Corporation (NASDAQ:CYTR)
Show:
DateFirmActionRatingPrice TargetDetails
1/22/2017HC WainwrightSet Price TargetBuy$4.00View Rating Details
11/14/2016FBR & CoSet Price TargetBuy$3.00View Rating Details
7/15/2016Jefferies Group LLCReiterated RatingHold$2.50 -> $0.75View Rating Details
7/12/2016S&P Equity ResearchLower Price Target$1.04 -> $0.75View Rating Details
3/28/2016AegisBoost Price TargetBuy$9.00 -> $12.00View Rating Details
11/6/2015Oppenheimer Holdings, Inc.Reiterated RatingOutperform$10.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for CytRx Corporation (NASDAQ:CYTR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/9/2017        
7/29/2016Q2($0.19)($0.27)ViewN/AView Earnings Details
5/11/2016Q116($0.26)($0.19)ViewN/AView Earnings Details
11/3/2015Q315($0.24)($0.11)ViewN/AView Earnings Details
8/3/2015Q215($0.27)($0.21)ViewN/AView Earnings Details
5/1/2015Q115($0.21)$0.31ViewN/AView Earnings Details
3/10/2015($0.27)($0.24)ViewN/AView Earnings Details
11/4/2014Q314($0.25)($0.10)ViewN/AView Earnings Details
8/6/2014Q214($0.20)($0.28)ViewN/AView Earnings Details
5/1/2014Q413($0.18)$0.09ViewN/AView Earnings Details
3/5/2014($0.17)($0.25)ViewN/AView Earnings Details
10/29/2013Q313($0.22)($0.33)$0.20 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.19)($0.11)ViewN/AView Earnings Details
5/9/2013Q113($0.15)($0.23)ViewN/AView Earnings Details
3/11/2013Q4 2012($0.20)($0.21)ViewN/AView Earnings Details
11/9/2012Q312$0.07ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CytRx Corporation (NASDAQ:CYTR)
Current Year EPS Consensus Estimate: $-0.7000 EPS
Next Year EPS Consensus Estimate: $-0.5000 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.21)($0.21)($0.21)
Q2 20163($0.22)($0.17)($0.19)
Q3 20163($0.22)($0.12)($0.18)
Q4 20163($0.36)($0.12)($0.23)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for CytRx Corporation (NASDAQ:CYTR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CytRx Corporation (NASDAQ:CYTR)
Insider Ownership Percentage: 12.40%
Institutional Ownership Percentage: 20.19%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/3/2013Scott Bradford Pattersonmajor shareholderBuy284,979$2.44$695,348.76View SEC Filing  
11/7/2013Scott Bradford PattersonMajor ShareholderBuy50,000$2.06$103,000.00View SEC Filing  
4/1/2013Scott Bradford PattersonMajor ShareholderBuy4,083$2.70$11,024.10View SEC Filing  
3/20/2013Scott Bradford PattersonMajor ShareholderBuy3,980$2.61$10,387.80View SEC Filing  
3/13/2013Scott Bradford PattersonMajor ShareholderBuy55,360$2.67$147,811.20View SEC Filing  
10/22/2012Scott Bradford PattersonMajor ShareholderBuy180,000$2.51$451,800.00View SEC Filing  
10/18/2012Scott Bradford PattersonMajor ShareholderBuy1,200,000$2.50$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CytRx Corporation (NASDAQ:CYTR)
DateHeadline
News IconMarket Scope: Viewing Shares of CytRx Corporation (NASDAQ:CYTR) - Midway Monitor (NASDAQ:CYTR)
midwaymonitor.com - February 21 at 5:55 PM
News Icon33 institutional investors are raising stakes in CytRx Corporation ... - Post Analyst (NASDAQ:CYTR)
postanalyst.com - February 19 at 11:08 AM
News IconStock Value Analysis: CytRx Corporation (NASDAQ:CYTR) - The Oracle Examiner (NASDAQ:CYTR)
oracleexaminer.com - February 16 at 2:00 PM
News IconIs The Sell-Side Predicting That CytRx Corporation (NASDAQ:CYTR) Will Move Higher? - Winfield Review (NASDAQ:CYTR)
winfieldreview.com - February 16 at 2:00 PM
News IconInvestor's Alert: EverBank Financial Corp. (NYSE:EVER), CytRx ... - The Newburgh Press (NASDAQ:CYTR)
newburghpress.com - February 16 at 2:00 PM
News IconTechnical Trading: Focus on Shares of CytRx Corporation (CYTR) - Rives Journal (NASDAQ:CYTR)
rivesjournal.com - February 14 at 5:30 PM
News IconTrading Monitor: Watching Shares of CytRx Corporation (CYTR) - Davidson Register (NASDAQ:CYTR)
davidsonregister.com - February 10 at 10:06 PM
News IconPolarityTE Inc. Appoints Regenerative Medicine Pioneer Steve Gorlin to the Board of Directors (NASDAQ:CYTR)
www.broadwayworld.com - February 9 at 5:08 PM
finance.yahoo.com logoCytRx to Present at the 19th Annual BIO CEO & Investor Conference (NASDAQ:CYTR)
finance.yahoo.com - February 6 at 4:41 PM
News IconCytRx Corporation (NASDAQ:CYTR) Bearish Target At $4 - Stock Observer (NASDAQ:CYTR)
www.thestockobserver.com - February 3 at 4:58 PM
News IconCytRx Corporation (NASDAQ:CYTR) could surge as high as $4 - The Newburgh Press (NASDAQ:CYTR)
newburghpress.com - February 3 at 4:58 PM
News IconSmall Cap Concentration on CytRx Corporation (NASDAQ:CYTR) - Prospect Journal (NASDAQ:CYTR)
prospectjournal.com - January 31 at 5:19 PM
biz.yahoo.com logoCYTRX CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CYTR)
biz.yahoo.com - January 30 at 9:52 AM
News IconQuarterly EPS Of CytRx Corporation (NASDAQ:CYTR) Set At $-0.11 - Stock Observer (NASDAQ:CYTR)
www.thestockobserver.com - January 29 at 9:44 PM
News IconEarnings in Full Force, Analysts Take Aim at CytRx Corporation (NASDAQ:CYTR) - Wall Street Beacon (NASDAQ:CYTR)
wsbeacon.com - January 28 at 9:54 PM
News IconStock Trading Analysis on CytRx Corporation (CYTR) - Highland Mirror (NASDAQ:CYTR)
www.highlandmirror.com - January 26 at 5:52 PM
News IconCytRx Corporation (NASDAQ:CYTR) Quarterly Analysis - The Newburgh Press (NASDAQ:CYTR)
newburghpress.com - January 24 at 10:20 PM
News IconWhat are Analysts Expecting for CytRx Corporation (NASDAQ:CYTR) Earnings? - Aiken Advocate (NASDAQ:CYTR)
aikenadvocate.com - January 24 at 2:58 AM
News IconCytRx Corporation (NASDAQ:CYTR):Brokerage Firm Rating ... - RSS - Highland Mirror (NASDAQ:CYTR)
www.highlandmirror.com - January 23 at 4:57 PM
News IconCytRx Corporation (NASDAQ:CYTR) Quarterly EPS Set At $-0.11 ... - Stock Observer (NASDAQ:CYTR)
www.thestockobserver.com - January 22 at 4:36 PM
News IconHewlett Packard Enterprise buys converged infrastructure startup SimpliVity for $650 million (NASDAQ:CYTR)
perspectivabetica.com - January 17 at 10:30 PM
News IconTraders Watch list: CytRx Corporation (NASDAQ:CYTR), Tenet Healthcare Corp. (NYSE:THC) - The Newburgh Press (NASDAQ:CYTR)
newburghpress.com - January 15 at 4:30 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: CytRx Corporation (NASDAQ:CYTR) - Wall Street Beacon (NASDAQ:CYTR)
wsbeacon.com - January 15 at 4:30 PM
News IconCan This Stock Pick Up Any Momentum: CytRx Corporation (NASDAQ:CYTR) - Prospect Journal (NASDAQ:CYTR)
prospectjournal.com - January 12 at 3:10 AM
News IconCytRx Corp CYTR Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CYTR)
www.bioportfolio.com - January 7 at 3:07 AM
News IconSoft Brexit could take independence 'off table' in short term (NASDAQ:CYTR)
www.newsoneplace.com - January 6 at 10:06 PM
smarteranalyst.com logoCompany Update (NASDAQ:CYTR): Here's Why CytRx Corporation Shares Are Rising 11% - Smarter Analyst (NASDAQ:CYTR)
www.smarteranalyst.com - January 6 at 5:05 PM
News IconUN health agency fills gap in HIV treatment for patients in Libya (NASDAQ:CYTR)
www.newsoneplace.com - January 6 at 3:23 AM
News IconBearish Target Of CytRx Corporation (NASDAQ:CYTR) At $10 - Stock Observer (NASDAQ:CYTR)
www.thestockobserver.com - January 5 at 10:21 PM
reuters.com logoBRIEF-Cytrx granted type b pre-nda meeting with U.S. FDA for registration pathway with aldoxorubicin (NASDAQ:CYTR)
www.reuters.com - January 4 at 5:42 PM
finance.yahoo.com logoCytRx Granted Type B Pre-NDA Meeting with U.S. FDA for Registration Pathway with Aldoxorubicin as a Treatment … (NASDAQ:CYTR)
finance.yahoo.com - January 4 at 5:42 PM
smarteranalyst.com logoCompany Update (NASDAQ:CYTR): Here’s Why CytRx Corporation Shares Are Rising 11% (NASDAQ:CYTR)
www.smarteranalyst.com - January 4 at 5:42 PM
publicnow.com logoCytRx Granted Type B Pre-NDA Meeting with U.S. FDA for Registration Pathway with Aldoxorubicin as a Treatment for Patients with Relapsed Soft Tissue Sarcomas (NASDAQ:CYTR)
www.publicnow.com - January 4 at 5:42 PM
News IconAre These Shares a Bargain: Update on CytRx Corporation (NASDAQ:CYTR) - Prospect Journal (NASDAQ:CYTR)
prospectjournal.com - January 3 at 6:21 PM
News IconComposite Score Check on CytRx Corporation (NASDAQ:CYTR) - Wall Street Beacon (NASDAQ:CYTR)
wsbeacon.com - January 3 at 6:21 PM
News IconQuarterly EPS Of CytRx Corporation (NASDAQ:CYTR) At $-0.11 - Stock Observer (NASDAQ:CYTR)
www.thestockobserver.com - January 1 at 9:35 PM
investornewswire.com logoCytRx Corporation (NASDAQ:CYTR) Records An Impact Score Of 0 - Investor Newswire (NASDAQ:CYTR)
www.investornewswire.com - December 30 at 10:02 PM
News IconAre the Technicals Adding up for CytRx Corporation (NASDAQ:CYTR) - Prospect Journal (NASDAQ:CYTR)
prospectjournal.com - December 30 at 10:02 PM
nasdaq.com logoIs the Options Market Predicting a Spike in CytRx Corp (CYTR) Stock? - Nasdaq (NASDAQ:CYTR)
www.nasdaq.com - December 30 at 10:02 PM
finance.yahoo.com logoIs the Options Market Predicting a Spike in CytRx Corp (CYTR) Stock? (NASDAQ:CYTR)
finance.yahoo.com - December 30 at 5:01 PM
News IconStock's Trend Analysis Report: E*TRADE Financial Corporation (NASDAQ:ETFC), CytRx Corporation (NASDAQ:CYTR) - The Newburgh Press (NASDAQ:CYTR)
newburghpress.com - December 29 at 5:01 PM
News IconBRIEF-BB&T says sold $850 mln of floating rate medium-term notes, Series E - SEC filing (NASDAQ:CYTR)
www.newsoneplace.com - December 28 at 12:00 PM
News IconRussian military plane disappears on route from Sochi to Syria (NASDAQ:CYTR)
avauncer.com - December 26 at 11:34 AM
News IconGoodwill Gesture: 220 Indian fishermen freed by Pakistan on Christmas (NASDAQ:CYTR)
avauncer.com - December 25 at 4:27 PM
reuters.com logoBRIEF-Cytrx Corp says files for mixed shelf offering of up to $200 mln- SE... - Reuters (NASDAQ:CYTR)
in.reuters.com - December 22 at 4:49 PM
publicnow.com logoCytRx Appoints Chief Medical Officer Dr. Daniel Levitt as Chief Operating Officer (NASDAQ:CYTR)
us.rd.yahoo.com - December 21 at 3:32 AM
streetinsider.com logoForm 4 CYTRX CORP For: Dec 15 Filed by: KRIEGSMAN STEVEN A - StreetInsider.com (NASDAQ:CYTR)
www.streetinsider.com - December 20 at 10:31 PM
streetinsider.com logoForm 4 CYTRX CORP For: Dec 15 Filed by: Brien Earl W - StreetInsider.com (NASDAQ:CYTR)
www.streetinsider.com - December 20 at 9:46 AM
smarteranalyst.com logoCompany Update (NASDAQ:CYTR): CytRx Corporation Appoints Chief Medical Officer Dr. Daniel Levitt as Chief ... - Smarter Analyst (NASDAQ:CYTR)
www.smarteranalyst.com - December 20 at 9:46 AM
News IconInvestor Wire: Keeping an Eye on CytRx Corporation (NASDAQ:CYTR) - Business Daily Leader (NASDAQ:CYTR)
businessdailyleader.com - December 18 at 9:45 PM

Social

What is CytRx Corporation's stock symbol?

CytRx Corporation trades on the NASDAQ under the ticker symbol "CYTR."

Where is CytRx Corporation's stock going? Where will CytRx Corporation's stock price be in 2017?

4 brokerages have issued twelve-month price objectives for CytRx Corporation's shares. Their predictions range from $0.75 to $12.00. On average, they expect CytRx Corporation's share price to reach $4.10 in the next year.

When will CytRx Corporation announce their earnings?

CytRx Corporation is scheduled to release their next quarterly earnings announcement on Thursday, March, 9th 2017.

Who owns CytRx Corporation stock?

CytRx Corporation's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (1.00%).

Who bought CytRx Corporation stock? Who is buying CytRx Corporation stock?

CytRx Corporation's stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp.

How do I buy CytRx Corporation stock?

Shares of CytRx Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of CytRx Corporation stock cost?

One share of CytRx Corporation stock can currently be purchased for approximately $0.46.

CytRx Corporation (NASDAQ:CYTR) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for CytRx Corporation (NASDAQ:CYTR)

Earnings History Chart

Earnings by Quarter for CytRx Corporation (NASDAQ:CYTR)

Dividend History Chart

Dividend Payments by Quarter for CytRx Corporation (NASDAQ:CYTR)

Last Updated on 2/22/2017 by MarketBeat.com Staff